ArticleUpdates in surgery2026
Preoperative prognostic nutritional index in prediction of surgical complications and oncological outcomes in retroperitoneal sarcoma.
Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Is the CALLY Index the Best Tool for Predicting Survival in Patients with Primary Soft Tissue Sarcomas?Diagnostics (Basel, Switzerland) · 2026Article
- Reply to the letter regarding "preoperative prognostic nutritional index in prediction of surgical complications and oncological outcomes in retroperitoneal sarcoma".Updates in surgery · 2026Article
- Comment on "Preoperative prognostic nutritional index in prediction of surgical complications and oncological outcomes in retroperitoneal sarcoma".Updates in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nutritional status is a potentially modifiable factor influencing outcomes in retroperitoneal sarcoma (RPS), yet reliable preoperative markers remain underexplored. The prognostic nutritional index (PNI), which combines serum albumin and lymphocyte count, may offer a simple, reproducible tool for risk stratification. We conducted a retrospective cohort study of adult patients undergoing curative-intent resection of primary or recurrent RPS between 2020 and 2024 at a Latin American tertiary center. Patients were stratified by a PNI cutoff of 40, derived via ROC analysis. The primary endpoint was the incidence of major postoperative complications (Clavien-Dindo ≥ III), while secondary endpoints included overall survival (OS) and recurrence-free survival (RFS). Multivariable logistic and Cox regression models were used to assess independent predictors. Among 142 patients, 52.1% had a low PNI (≤ 40). Major complications occurred in 27.6% of patients and were significantly more freq uent in the low-PNI group (37.8% vs. 16.2%, p = 0.006). Low PNI independently predicted significant morbidity (OR 2.72, 95% CI 1.18-6.29, p = 0.018), alongside operative time and intraoperative transfusion. After a median follow-up of 39 months, low PNI was associated with inferior 3-year OS (55% vs. 74%, p = 0.008) and RFS (44% vs. 63%, p = 0.022). On multivariable analysis, low PNI remained a significant predictor of OS (HR 1.98, p = 0.019) and RFS (HR 1.67, p = 0.037). A preoperative PNI ≤ 40 identifies RPS patients at increased risk for significant complications and inferior survival, independent of tumor grade or surgical extent. These findings remained consistent across sensitivity analyses restricted to primary RPS, support the integration of PNI into perioperative risk stratification and nutritional optimization strategies.
Indexed as
Identifiers
41644814What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.